Wedbush Reiterates Outperform on IDEAYA Biosciences, Maintains $43 Price Target
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Robert Driscoll has reiterated an Outperform rating on IDEAYA Biosciences (NASDAQ:IDYA) and maintained a price target of $43.

November 13, 2023 | 1:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst reaffirms Outperform rating on IDEAYA Biosciences with a $43 price target, indicating a positive outlook on the stock.
The reiteration of an Outperform rating by a reputable analyst like Robert Driscoll from Wedbush is a strong positive signal for investors, suggesting that the analyst has a bullish outlook on the stock's future performance. The maintained price target of $43 implies a potential upside from the current trading price, which could influence investor sentiment and drive short-term price movement in a positive direction.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100